TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Shionogi & Co ( (JP:4507) ).
Shionogi & Co., Ltd. has successfully completed the acquisition of Japan Tobacco Inc.’s pharmaceutical business and the shares of Akros Pharma Inc., enhancing its market presence and operational capabilities in the pharmaceutical industry. This strategic move is expected to strengthen Shionogi’s position in the healthcare market, potentially offering new opportunities for growth and development in its pharmaceutical operations.
The most recent analyst rating on (JP:4507) stock is a Buy with a Yen3119.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan. The company is primarily focused on the development, manufacturing, and marketing of pharmaceutical products, with a strong emphasis on research and innovation in the healthcare sector.
YTD Price Performance: 24.07%
Average Trading Volume: 2,597,308
Technical Sentiment Signal: Buy
Current Market Cap: Yen2357.6B
See more data about 4507 stock on TipRanks’ Stock Analysis page.